Company profile for Amagma Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Amagma was founded in 2019 by serial entrepreneurs Tillman Gerngross, Ph.D. and Leonard Zon, M.D., to develop novel antibody therapies targeting diseases resulting from the dysfunction of essential proteases and other enzymes. These targets have long been of interest to the biopharmaceutical industry, but, despite this, there remain significant unmet medical needs across the many inflammatory conditions caused by protease dysf...
Amagma was founded in 2019 by serial entrepreneurs Tillman Gerngross, Ph.D. and Leonard Zon, M.D., to develop novel antibody therapies targeting diseases resulting from the dysfunction of essential proteases and other enzymes. These targets have long been of interest to the biopharmaceutical industry, but, despite this, there remain significant unmet medical needs across the many inflammatory conditions caused by protease dysfunction. We believe that antibodies hold the greatest potential to successfully address these needs and have built a proprietary platform.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
100 Beaver Street Suite 307 Waltham, MA 02453
Telephone
Telephone
781 472 2230
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Triveni raises $92M for I&I pipeline after Modify, Amagma merger
Triveni raises $92M for I&I pipeline after Modify, Amagma merger

26 Oct 2023

// Gabrielle Masson FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/triveni-raises-92m-ii-pipeline-after-modify-amagma-merger

Gabrielle Masson FIERCE BIOTECH
26 Oct 2023

https://endpts.com/tillman-gerngross-amagma-therapeutics-quietly-ships-antibodies-to-another-biotech/

Kyle LaHucik ENDPTS
15 Feb 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty